Procedures & recovery · patient guide

TURP and hoLEP: questions to settle first

TURP and hoLEP are two operations that remove obstructing prostate tissue to relieve lower urinary tract symptoms from an enlarged prostate. They are not interchangeable for every man, and the choice depends on prostate size and shape, your general health, medicines, prior surgery and what the treating urologist can safely offer. Settle these questions with the surgical team before you plan travel.

Go to the practical guidance ↓
AI illustration: A doctor in a white coat consulting with a concerned older male patient in a room with traditional Asian architecture visible outside the window.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

What each operation actually does

Transurethral resection of the prostate (TURP) removes prostate tissue through the urethra using an instrument passed without an abdominal incision. Holmium laser enucleation of the prostate (hoLEP) uses a holmium laser to separate and remove obstructing prostate tissue, again through the urethra. Both aim to open the channel that urine passes through, and both produce tissue that can be examined in a laboratory.

The practical difference for a patient is not simply 'laser versus electricity'. The two techniques differ in how tissue is cut and removed, how bleeding is controlled, and how the surgeon judges the amount of tissue taken. Those technical points belong to the operating urologist, who should explain why one approach fits your prostate and health rather than presenting a single default.

Ask the team to describe the proposed operation in plain language: what will be removed, how, and what will be left in place afterwards. If a hospital offers only one of the two techniques, that is a service fact to confirm, not a reason to assume the other is unsuitable or unavailable elsewhere.

Which questions decide the choice

The first question is whether surgery is the right step at all. Symptoms such as a weak stream, hesitancy, night-time urination or incomplete emptying can have several causes, and medicines or other treatments may be appropriate first. The urologist should explain why an operation is being proposed now and what the alternatives are, including continued observation or drug treatment where relevant.

The second question concerns your prostate and your body. Prostate size and shape, the presence of a middle lobe, previous prostate or urethral surgery, bladder function and any narrowing of the urethra can all influence which technique a surgeon recommends. So can your general fitness, bleeding risk and the medicines you take, particularly blood thinners. These are clinical judgements for the treating team, not points a coordinator can settle.

The third question is what you want from treatment. Relief of obstruction and improvement in flow are the usual goals, but urinary control and sexual function matter to many men and should be discussed explicitly. Ask the surgeon what changes in continence and ejaculation are associated with the proposed operation in your circumstances, and what the team does if symptoms persist afterwards.

  • Ask why surgery now rather than another option
  • Ask which technique is proposed and why it suits your prostate
  • Ask how your medicines, especially blood thinners, affect planning
  • Ask what the operation may change for urinary control and sexual function
  • Ask what follow-up and repeat assessment would involve

Records the urology team will want to see

A useful first enquiry is not a full medical archive. Start with a short summary of your symptoms, how long they have lasted, your current diagnosis if you have one, and the main question you want answered. After that first contact, the team can tell you which documents would help a records-based discussion.

For an enlarged prostate, relevant records often include recent urinary flow and residual-volume assessments, prostate imaging, blood tests including prostate-specific antigen where it has been measured, a medication list, and any previous urology correspondence or operation notes. Whether each item is needed, and how recent it should be, is for the receiving urologist to confirm. Do not arrange new tests on your own before that discussion.

If a biopsy or prostate cancer assessment is part of your history, say so clearly at the start. Cancer treatment and benign prostate enlargement are different clinical problems, and the questions, records and specialists involved are not the same.

Related treatment reference

Anaesthesia, catheter and the hospital stay

Both TURP and hoLEP are commonly performed under spinal or general anaesthesia, but the anaesthetic plan depends on your health and the anaesthetist's assessment. Ask who will make that decision, what pre-operative checks are required, and when you would be asked to stop eating or adjust regular medicines. Those instructions must come from the treating team, not from a travel organiser.

A urinary catheter after surgery is expected with these operations, but how long it stays, whether you go home with it, and what to do if it blocks or stops draining are questions for the surgeon and ward team. Ask for written instructions on catheter care, fluid intake, when to seek urgent help, and who to contact locally if something goes wrong after discharge.

Consent discussions should happen before sedation, when you can ask questions and understand the answers. Ask about the specific risks the surgeon associates with your case, including bleeding, infection, narrowing of the urethra and the possibility that tissue will need laboratory examination. Do not rely on a general leaflet alone.

What to confirm about care in China

Hospitals in China differ in which prostate operations their urology departments perform, how wards are organised, and what language support is available. Rather than assuming a particular technique is offered at a particular hospital, ask the provider directly. A useful question is whether the urology team routinely performs the operation being discussed and how it handles patients who travel from abroad.

Ask what the written treatment plan and quote include, and what is paid separately. Hospital fees, our coordination fees and travel costs are distinct, and the scope of an estimate should be confirmed in writing rather than inferred. Ask whether a standard ward or an international department is proposed, and what that changes for communication, visiting and discharge.

Follow-up is part of the decision. Ask how post-operative review would be arranged, what would happen if you returned home before all checks were complete, and which clinician would take responsibility for ongoing care. The receiving team decides suitability and acceptance; an initial enquiry does not establish that surgery will be offered.

A practical next step

If you are weighing TURP against hoLEP, write down your three main questions before contacting anyone: why surgery now, which technique and why, and what follow-up would require you to stay. A free initial enquiry can review the summary you provide, identify missing information and suggest a relevant next step. It is not a diagnosis, and it does not commit you to a proxy consultation or to travelling.

You can send a brief summary through the enquiry form, by email or by WhatsApp. Share records only after the team explains what would be useful. The urology team at the treating hospital makes the clinical decision about which operation, if any, is appropriate for you.

Sources & scope of this guide

References and official service information relevant to this guide.

  1. Related treatment reference
  2. European Association of Urology guidelines on non-neurogenic male lower urinary tract symptoms
  3. American Urological Association guideline on benign prostatic hyperplasia
  4. NHS information on transurethral resection of the prostate

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.